Overview
- 5 FDA inspections are on record.
- 3 inspections produced a Form 483.
- The most recent recorded inspection date is 2026-06-04.
At a glance
Inspections
5
Form 483s
3
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 27 May 2026 – 4 Jun 2026 | Human Drugs | 483 | View 483 → |
| 2 Nov 2023 – 7 Nov 2023 | Human Drugs | Clean | |
| 23 May 2022 – 25 May 2022 | Human Drugs | Clean | |
| 19 Nov 2019 – 22 Nov 2019 | Human Drugs | 483 | View 483 → |
| 30 Oct 2014 – 5 Nov 2014 | Human Drugs | 483 | On file |
Observations on record
Form 483 observations cited at this site, most recent first.
4 Jun 2026
21 CFR 211.122(a)
Written procedures describing in detail
Cited by JeanClaude Garay, Chikitsa S Patel
4 Jun 2026
21 CFR 211.182
Written records kept in individual logs
Cited by JeanClaude Garay, Chikitsa S Patel
4 Jun 2026
21 CFR 211.192
Written record of investigation incomplete
Cited by JeanClaude Garay, Chikitsa S Patel
4 Jun 2026
21 CFR 211.194(a)(2)
Laboratory Test Method Verification
Cited by JeanClaude Garay, Chikitsa S Patel
4 Jun 2026
21 CFR 211.22(a)
Authority lacking to review records, investigate errors
Cited by JeanClaude Garay, Chikitsa S Patel
Investigators
FDA investigators tied to this site in the record.
Vaishali J Patel2 insp.
JeanClaude Garay1 insp.
Chikitsa S Patel1 insp.
Jeanne J Thai1 insp.
Yuanyuan Li1 insp.
Andrew J Barrowcliff1 insp.
Christina A Miller1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.122(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.182 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(2) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Nexus Pharmaceuticals, LLC's 3 Form 483s
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat